METheraHld (METX:CSE) closed at $1.10 on October 29, 2026, unchanged on the day. The stock trades 79.4% below its 52-week high of $5.35 and 39.2% above its 52-week low of $0.790. Over the past year, it lost 79.4%. METheraHld is part of the Life Sciences sector.
In 252 trading sessions since October 30, 2025, METX closed higher on 32 days (13%). Its best day was September 15, 2026 (+87.50%) and its worst was September 18, 2026 (-57.32%). The stock moved 10% or more in a single session 40 times. It opened at least 5% above the previous day's high 20 times.
ME Therapeutics is a pre-clinical biopharmaceutical company dedicated to the discovery and development of novel cancer immunotherapies. Using our combined expertise in tumour immunology, T cell biology and myeloid cell development, we are developing biological and small molecule drugs to target novel pathways involved in cancer-induced immune suppression. Our therapies have the potential to work on their own and in combination with other cancer immunotherapies across several cancer types.
Find more stocks like METX with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.